Art of selecting antimigrenous therapy. Treatment of migraine attack
Abstract
Acute migraine treatment is challenging. Migraine medications are effective in two out of the three attacks only. Individual response to an analgesics is difficult predictable. Migraine attack treatment is often ineffective on account of non-compliance with the rules for the use of analgesics. Acute migraine medications should be used as early as possible after the onset of headache phase. The effective choice for a migraine patient depends on the severity of the attacks, associated symptoms particularly nausea and vomiting, comorbid disorders, and the individual patient's response. A stratified approach based on the patient’s therapeutic needs has been discussed.
About the Author
A. V. Sergeev
First Moscow State Medical University n.a. I. M. Sechenov
Russian Federation
Russian Federation
References
1. Steiner TJ, Gururaj G, Andrée C, Katsarava Z, Ayzenberg I, Yu SY, Al Jumah M, Tekle-Haimanot R, Birbeck GL, Herekar A, Linde M, Mbewe E, Manandhar K, Risal A, Jensen R, Queiroz LP, Scher AI, Wang SJ, Stovner LJ. Diagnosis, prevalence estimation and burden measurement in population surveys of headache: presenting the HARDSHIP questionnaire. J Headache Pain. 2014. Jan 8; 15:3.
2. Schou WS, Ashina S, Amin FM, Goadsby PJ, Ashina M. Calcitonin gene-related peptide and pain: a systematic review. J Headache Pain. 2017 Dec; 18 (1): 34.
3. Табеева Г. Р. Рациональная комбинированная терапия приступа мигрени. Consilium medicum. 2013.-N9.-С. 18-23.
4. Сергеев А. В. Доказательная терапия приступа мигрени. Consilium Medicum. Неврология и ревматология. (Прил.) 2015; 01: 34-37.
5. Acute migraine treatment in emergency settings. Comparative Effectiveness Review Summary Guides for Clinicians. Agency for Healthcare Research and Quality. www. ncbi.nlm.nih.gov/books/NBK164542/ (Accessed on November25, 2013).
6. Первичные головные боли. Практическое руководство. / В. В. Осипова, Г. Р. Табеева. -М.:, ООО «ПАГРИ-Принт», 2007.-60 с.
7. Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, Sândor PS. EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force. Eur J Neurol. 2009 Sep; 16 (9): 968-81.
8. Lipton RB, Stewart WF, Stone AM, et al. Stratified care vs step care strategies for migraine: the Disability in Strategies of Care (DISC) Study: A randomized trial. JAMA 2000; 284: 2599.
9. Pringsheim T, Becker WJ. Triptans for symptomatic treatment of migraine headache. BMJ 2014; 348: g 2285.
10. Roberto G, Raschi E, Piccinni C, et al. Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: systematic review of observational studies. Cephalalgia 2015; 35: 118.
11. Hall GC, Brown MM, Mo J, MacRae KD. Triptans in migraine: the risks of stroke, cardiovascular disease, and death in practice. Neurology 2004; 62: 563.
12. Christoph-Diener H, Ferrari M, Mansbach H, SNAP Database Study Group. Predicting the response to sumatriptan: the Sumatriptan Naratriptan Aggregate Patient Database. Neurology 2004; 63: 520.
13. Burstein R, Collins B, Jakubowski M. Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Ann Neurol 2004; 55: 19.
14. BET 1: Metoclopramide or prochlorperazine for headache in acute migraine? Emerg Med J 2013; 30: 595.
15. Шагбазян А.Э., Сергеев А. В., Евдокимова Е. М., Курбанбагамаева Р. Р., Табеева Г. Р. Роль эмоциональных и поведенческих расстройств в формировании лекарственной зависимости у пациентов с медикаментозно-индуцированной головной болью (обзор). Неврология, нейропсихиатрия, психосоматика. 2016; 8 (3): 76-81.
16. Colman I, Friedman BW, Brown MD, et al. Parenteral dexamethasone for acute severe migraine headache: meta-analysis of randomised controlled trials for preventing recurrence. BMJ 2008; 336: 1359.
Review
For citations:
Sergeev A.V. Art of selecting antimigrenous therapy. Treatment of migraine attack. Medical alphabet. 2018;1(1):26-31. (In Russ.)
Views:
309
Email this article 